about
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adultsHIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 studyHIV protease inhibitors: a review of molecular selectivity and toxicityThe potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection.The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replicationImpact of highly active antiretroviral therapy on oral manifestations of patients with human immunodeficiency virus/acquired immuno deficiency syndrome in South IndiaQuality of life of people living with HIV and AIDS and antiretroviral therapy.Clinically informative measures of the effect of drugs or other interventions.Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.Antiviral drugs and the treatment of hepatitis C.Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS.Relationship between acceptance of HIV/AIDS and functional outcomes assessed in a primary care setting.Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy.Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discoveryTenofovir-induced renal tubular dysfunction among human immunodeficiency virus patients on antiretroviral therapy in Nigeria: Prospects for early detection of presymptomatic nephrotoxicity
P2860
Q24246038-D79E8A92-1166-48FD-8A3D-716BE0B9EF86Q24791416-46FE6195-9988-47D1-961F-131C7147F718Q28082749-929C43F6-5734-4CE1-A3C9-4EFF928CA40DQ30429050-82F7A708-0055-40B1-9B54-5AE4D895A408Q34141571-55D52106-1548-4DFB-8B11-26E4491864E4Q36014827-D75FDDE2-B544-4AD5-9370-64B5F9E5CBC6Q36163197-9C4D01E7-B26D-44A3-BA9E-E20AC7DF2415Q37110309-5CAB62B2-5660-49DE-9C8C-844879F46E9FQ37117942-E5025039-45B3-4C1A-97FD-CB9030D2C440Q37987057-FC38FF5E-8539-4841-98E8-969EB990F705Q37999051-93BE3098-EB7D-49EE-8159-FA346DE9A31DQ38091148-A2DC5DFF-FF53-4B0D-8B4F-0688118F6E67Q39928392-59769744-4037-45CF-BCE5-3A73F745C770Q49462231-07B61FE4-8C21-434F-A55E-679FFD96D3FCQ56749607-F73911CF-7B62-48ED-9D5B-A2183C592691Q58795390-98D5A919-5C23-4365-8D82-3B66FA252EB0
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
ABC of AIDS. Antiretroviral drugs
@ast
ABC of AIDS. Antiretroviral drugs
@en
type
label
ABC of AIDS. Antiretroviral drugs
@ast
ABC of AIDS. Antiretroviral drugs
@en
prefLabel
ABC of AIDS. Antiretroviral drugs
@ast
ABC of AIDS. Antiretroviral drugs
@en
P1433
P1476
ABC of AIDS. Antiretroviral drugs
@en
P2093
Williams IG
P304
P356
10.1136/BMJ.322.7299.1410
P407
P577
2001-06-01T00:00:00Z